GURUFOCUS.COM » STOCK LIST » Industrials » Construction » Nova Pharma Solutions Bhd (XKLS:03006) » Definitions » Price-to-Owner-Earnings

Nova Pharma Solutions Bhd (XKLS:03006) Price-to-Owner-Earnings : 4.60 (As of May. 26, 2024)


View and export this data going back to 2018. Start your Free Trial

What is Nova Pharma Solutions Bhd Price-to-Owner-Earnings?

As of today (2024-05-26), Nova Pharma Solutions Bhd's share price is RM0.23. Nova Pharma Solutions Bhd's Owner Earnings per Share (TTM) ended in Dec. 2023 was RM0.05. It's Price-to-Owner-Earnings for today is 4.60.


The historical rank and industry rank for Nova Pharma Solutions Bhd's Price-to-Owner-Earnings or its related term are showing as below:

XKLS:03006' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 4.89   Med: 25.56   Max: 76.67
Current: 4.89

During the past 9 years, the highest Price-to-Owner-Earnings of Nova Pharma Solutions Bhd was 76.67. The lowest was 4.89. And the median was 25.56.


XKLS:03006's Price-to-Owner-Earnings is not ranked
in the Construction industry.
Industry Median: 12.61 vs XKLS:03006: 4.89

As of today (2024-05-26), Nova Pharma Solutions Bhd's share price is RM0.23. Nova Pharma Solutions Bhd's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2023 was RM0.03. Therefore, Nova Pharma Solutions Bhd's PE Ratio for today is 8.85.

As of today (2024-05-26), Nova Pharma Solutions Bhd's share price is RM0.23. Nova Pharma Solutions Bhd's EPS without NRI for the trailing twelve months (TTM) ended in was RM0.03. Therefore, Nova Pharma Solutions Bhd's PE Ratio without NRI for today is 8.85.

During the past 9 years, Nova Pharma Solutions Bhd's highest PE Ratio without NRI was 76.67. The lowest was 8.85. And the median was 38.33.


Nova Pharma Solutions Bhd Price-to-Owner-Earnings Historical Data

The historical data trend for Nova Pharma Solutions Bhd's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Nova Pharma Solutions Bhd Price-to-Owner-Earnings Chart

Nova Pharma Solutions Bhd Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only - - 25.56 76.67 4.89

Nova Pharma Solutions Bhd Semi-Annual Data
Dec15 Dec16 Jun17 Dec17 Jun18 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25.56 - 76.67 - 4.89

Competitive Comparison of Nova Pharma Solutions Bhd's Price-to-Owner-Earnings

For the Engineering & Construction subindustry, Nova Pharma Solutions Bhd's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Nova Pharma Solutions Bhd's Price-to-Owner-Earnings Distribution in the Construction Industry

For the Construction industry and Industrials sector, Nova Pharma Solutions Bhd's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Nova Pharma Solutions Bhd's Price-to-Owner-Earnings falls into.



Nova Pharma Solutions Bhd Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Nova Pharma Solutions Bhd's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=0.23/0.05
=4.60

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Nova Pharma Solutions Bhd  (XKLS:03006) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Nova Pharma Solutions Bhd Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Nova Pharma Solutions Bhd's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Nova Pharma Solutions Bhd (XKLS:03006) Business Description

Traded in Other Exchanges
N/A
Address
Jalan USJ 25/1, Level 5, Suite C-5-1 & 2, Block C, Sky Park, One City, Subang Jaya, SGR, MYS, 47650
Nova Pharma Solutions Bhd provides engineering solutions to pharma and biotech industries. The company's reportable segments include Design fee, Post Design, & Other support fees. Design fee comprises conceptual designs which include user requirement specification, capacity analysis and process scheduling with detailed costing, list of deliverables, details specification of various equipment and processes. Post design fee comprise tendering and procurement support as well as the construction of a plant, & Other support fees comprise of services to assist a customer in the good manufacturing practice document review & gap analysis and assessment. It generates a majority of its revenue from the Design fee segment. Geographically, the company generates a majority of its revenue from Malaysia.

Nova Pharma Solutions Bhd (XKLS:03006) Headlines

No Headlines